LINICAL
White Papers
THE LATEST
November 18, 2026
Benefit-risk in early-phase trials: why PV must move from safety oversight to strategic decision partner
As uncertainty defines early-phase clinical development, how can proactive benefit-riskassessment and pharmacovigilance protect patients without...